Structure of sars-cov-2 s protein in complex with n-terminal domain antibody dh1052 Deposition Author(s): Acharya, P. , Manne, K.
Date: 2021-01-06 Method: ELECTRON MICROSCOPY Resolution: 2.97 Å Organism(s): Homo Sapiens , Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LAB_X , 7LAB_S , 7LAB_L , 7LAB_Y , 7LAB_T , 7LAB_H , 7LAB_A , 7LAB_B , 7LAB_C
Joint x-ray/neutron structure of sars-cov-2 main protease (3cl mpro) in complex with telaprevir Deposition Author(s): Coates, L. , Kneller, D.W. , Kovalevsky, A.Y.
Date: 2021-01-07 Method: X-RAY DIFFRACTION, NEUTRON DIFFRACTION Resolution: 2,2.4 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LB7_A
X-ray crystal structure of the sars-cov-2 main protease with calpain i inhibitor Deposition Author(s): Murakami, K.S. , Narwal, M.
Date: 2021-01-08 Method: X-RAY DIFFRACTION Resolution: 1.76 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 7LBN_A , 7LBN_D
Sars-cov-2 papain-like protease (plpro) bound to inhibitor xr8-89 Deposition Author(s): Ratia, K.M. , Thatcher, G.R. , Xiong, R.
Date: 2021-01-08 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LBR_A , 7LBR_B
Sars-cov-2 papain-like protease (plpro) bound to inhibitor xr8-24 Deposition Author(s): Ratia, K.M. , Thatcher, G.R. , Xiong, R.
Date: 2021-01-08 Method: X-RAY DIFFRACTION Resolution: 2.8 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LBS_A , 7LBS_B
Sars-cov-2 spike protein tm domain Deposition Author(s): Chou, J.J. , Fu, Q.
Date: 2021-01-10 Method: SOLUTION NMR Resolution: N.A. Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LC8_A , 7LC8_B , 7LC8_C
Structure of sars-cov-2 s protein in complex with n-terminal domain antibody dh1050.1 Deposition Author(s): Acharya, P. , Manne, K.
Date: 2021-01-11 Method: ELECTRON MICROSCOPY Resolution: 3.35 Å Organism(s): Homo Sapiens , Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LCN_C , 7LCN_A , 7LCN_K , 7LCN_H , 7LCN_B , 7LCN_M , 7LCN_L , 7LCN_D , 7LCN_S
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability Deposition Author(s): Arutyunova, E. , Khan, M.B. , Lemieux, M.J. , Lu, J. , Young, H.S.
Date: 2021-01-11 Method: X-RAY DIFFRACTION Resolution: 1.9 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LCO_A
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability Deposition Author(s): Arutyunova, E. , Khan, M.B. , Lemieux, M.J. , Young, H.S.
Date: 2021-01-11 Method: X-RAY DIFFRACTION Resolution: 1.95 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LCR_A , 7LCR_B
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability Deposition Author(s): Arutyunova, E. , Khan, M.B. , Lemieux, M.J. , Young, H.S.
Date: 2021-01-11 Method: X-RAY DIFFRACTION Resolution: 1.85 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LCS_A